News Johns Hopkins secures $15M NIH grant for AIDs research center The National Institutes of Health announced Friday it has awarded Johns Hopkins University $15 million to help establish the school’s…Super UserMay 9, 2012
News Federal Telemedicine News: Moving Research Forward TATRC within the Army’s Medical Research and Materiel Command is taking steps to move research forward according to the article…Super UserMay 9, 2012
News GlaxoSmithKline makes hostile Human Genome Sciences bid – Washington Business Journal GlaxoSmithKline PLC is taking its unsolicited $2.6 billion bid for Rockville-based Human Genome Sciences Inc. directly to the biotech's…Super UserMay 9, 2012
News National Heart, Lung and Blood Institute to Establish NHLBI Centers for Accelerated Innovations The National Heart, Lung, and Blood Institute (NHLBI) published a Funding Opportunity Announcement (FOA) in the Spring 2012 NIH Guide…Super UserMay 8, 2012
News We Can’t Wait Update: Advancing Innovation in Health Care | The White House From the electric light bulb to the Internet, American innovations have made lives better for people in this country and…Super UserMay 8, 2012
News We Can’t Wait: HHS announces first 26 Health Care Innovation awards Health and Human Services (HHS) Secretary Kathleen Sebelius today announced the first batch of organizations for Health Care Innovation awards.…Super UserMay 8, 2012
News Breaking the Genome Bottleneck – Technology Review The genomic data generated from next-generation sequencing machines doesn't amount to much more than alphabet soup if it's not subjected…Super UserMay 8, 2012
News Supernus moves from IPO to FDA – Washington Business Journal Supernus Pharmaceuticals Inc. capped off its first week on the Nasdaq up nearly $1 from its initial public offering price.…Super UserMay 7, 2012
News State biotech firms hoping Congress will act – baltimoresun.com A proposal to speed the approval of new prescription drugs has patient advocates and biotech firms — including many based…Super UserMay 5, 2012
News Should the FDA Approve More Drugs after Phase II? A Response to Matthew Herper – Forbes Last Friday, Forbes health care editor Matt Herper and I sat down to talk about my proposal, which I detailed…Super UserMay 5, 2012